HomeGENX • CVE
add
Genix Pharmaceuticals Corp
Previous close
$0.050
Day range
$0.040 - $0.040
Year range
$0.015 - $0.075
Market cap
2.37M CAD
Avg Volume
29.32K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | 71.00 | -95.51% |
Operating expense | 40.43K | -81.77% |
Net income | -59.06K | 73.99% |
Net profit margin | -83.18K | -479.60% |
Earnings per share | — | — |
EBITDA | 95.27K | 215.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.30K | -77.48% |
Total assets | 246.70K | -94.07% |
Total liabilities | 1.44M | 21.75% |
Total equity | -1.20M | — |
Shares outstanding | 59.22M | — |
Price to book | -2.50 | — |
Return on assets | -42.93% | — |
Return on capital | 16.19% | — |
Cash Flow
Net change in cash
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -59.06K | 73.99% |
Cash from operations | -42.56K | 17.30% |
Cash from investing | — | — |
Cash from financing | 40.23K | -51.81% |
Net change in cash | -2.33K | -107.29% |
Free cash flow | -47.14K | -44.68% |
About
Founded
1993
Headquarters
Website